0001209191-20-064066.txt : 20201217 0001209191-20-064066.hdr.sgml : 20201217 20201217163339 ACCESSION NUMBER: 0001209191-20-064066 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201215 FILED AS OF DATE: 20201217 DATE AS OF CHANGE: 20201217 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lawton Alison Frances CENTRAL INDEX KEY: 0001542650 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37722 FILM NUMBER: 201396499 MAIL ADDRESS: STREET 1: 39 ROBINSON ROAD CITY: LEXINGTON STATE: MA ZIP: 02420 FORMER NAME: FORMER CONFORMED NAME: LAWTON ALISON FRANCIS DATE OF NAME CHANGE: 20120216 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aeglea BioTherapeutics, Inc. CENTRAL INDEX KEY: 0001636282 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 464312787 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 805 LAS CIMAS PARKWAY STREET 2: SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78746 BUSINESS PHONE: (512) 942-2935 MAIL ADDRESS: STREET 1: 805 LAS CIMAS PARKWAY STREET 2: SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78746 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-12-15 0 0001636282 Aeglea BioTherapeutics, Inc. AGLE 0001542650 Lawton Alison Frances C/O AEGLEA BIOTHERAPEUTICS, INC. 805 LAS CIMAS PARKWAY, SUITE 100 AUSTIN TX 78746 1 0 0 0 Director Stock Option (right to buy) 9.09 2020-12-15 4 A 0 47200 0.00 A 2030-12-14 Common Stock 47200 47200 D The stock option vests and becomes exercisable in 36 equal monthly installments beginning on January 15, 2021 until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date. /s/ Charles N. York II, by power of attorney 2020-12-17